GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Gushengtang Holdings Ltd (HKSE:02273) » Definitions » Cash, Cash Equivalents, Marketable Securities

Gushengtang Holdings (HKSE:02273) Cash, Cash Equivalents, Marketable Securities : HK$1,456 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Gushengtang Holdings Cash, Cash Equivalents, Marketable Securities?

Gushengtang Holdings's quarterly cash, cash equivalents, marketable securities increased from Dec. 2022 (HK$1,143.90 Mil) to Jun. 2023 (HK$1,465.49 Mil) but then stayed the same from Jun. 2023 (HK$1,465.49 Mil) to Dec. 2023 (HK$1,456.49 Mil).

Gushengtang Holdings's annual cash, cash equivalents, marketable securities declined from Dec. 2021 (HK$1,265.99 Mil) to Dec. 2022 (HK$1,143.90 Mil) but then increased from Dec. 2022 (HK$1,143.90 Mil) to Dec. 2023 (HK$1,456.49 Mil).


Gushengtang Holdings Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Gushengtang Holdings's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gushengtang Holdings Cash, Cash Equivalents, Marketable Securities Chart

Gushengtang Holdings Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash, Cash Equivalents, Marketable Securities
Get a 7-Day Free Trial 211.89 423.60 1,265.99 1,143.90 1,456.49

Gushengtang Holdings Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cash, Cash Equivalents, Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,265.99 1,102.18 1,143.90 1,465.49 1,456.49

Gushengtang Holdings Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Gushengtang Holdings  (HKSE:02273) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Gushengtang Holdings Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Gushengtang Holdings's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Gushengtang Holdings (HKSE:02273) Business Description

Traded in Other Exchanges
N/A
Address
No. 419, Qingsha Road, Room 005, Dongchong Town, Nansha District, Guangzhou, CHN
Gushengtang Holdings Ltd is a traditional Chinese medicine (TCM) company. Through offline medical institutions and online healthcare platforms, it provides customers with a comprehensive range of TCM healthcare services and products to address diverse medical and healthcare management needs. As all of the Group's revenue is derived from the PRC.
Executives
Tu Zhiliang 2501 Other
Wumianshan Ltd. 2201 Interest of corporation controlled by you
Frandor Limited
Tu Family Holdings Limited
Trident Trust Company (singapore) Pte. Limited
Dream True Limited
Action Thrive Group Limited 2101 Beneficial owner
Fmr Llc 2201 Interest of corporation controlled by you
Eight Roads Holdings Limited 2201 Interest of corporation controlled by you
Fil Limited 2201 Interest of corporation controlled by you
Eight Roads Shareholdings Limited 2201 Interest of corporation controlled by you
Pandanus Partners L.p. 2201 Interest of corporation controlled by you
Pandanus Associates Inc. 2201 Interest of corporation controlled by you
Johnson Iv Edward C. 2301 Trustee
Johnson Abigail P. 2301 Trustee

Gushengtang Holdings (HKSE:02273) Headlines

No Headlines